Latest filing published 22 Jul 2026 for Angiodynamics INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jan Stern Reed discloses dealings in 4 companies, chiefly Angiodynamics Inc, AVITA Medical, Inc. and Stepan Co. The record holds 17 filings, for trades running from 31 December 2015 to 15 July 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 22 July 2026: a share grant, in Angiodynamics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations